Tumour thermotolerance, a physiological phenomenon involving vessel normalisation

References

• Stauffer PR, Goldberg SN. Introduction: Thermal ablation therapy. Int J Hyperthermia 2004; 20: 671–677
   PubMed Web of Science ®Google Scholar
• Shinohara K. Thermal ablation of prostate diseases: Advantages and limitations. Int J Hyperthermia 2004; 20: 679–697
   PubMed Web of Science ®Google Scholar
• Visaria RK, Griffin RJ, Williams BW, Ebbini ES, Paciotti GF, Song CW, Bischof JC. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol Cancer Ther 2006; 5: 1014–1020
   PubMed Web of Science ®Google Scholar
• Rhee JG, Schuman VL, Song CW, Levitt SH. Difference in the thermotolerance of mouse mammary carcinoma cells in vivo and in vitro. Cancer Res 1987; 47: 2571–2575
   PubMed Web of Science ®Google Scholar
• Song CW, Lin JC, Chelstrom LM, Levitt SH. The kinetics of vascular thermotolerance in SCK tumors of A/J mice. Int J Radiat Oncol Biol Phys 1989; 17: 799–802
   PubMed Web of Science ®Google Scholar
• Lin J-C, Song CW. Influence of vascular thermotolerance on the heat-induced changes in blood flow, pO2 and cell survival in tumors. Cancer Res 1993; 53: 2076–2080
   PubMed Web of Science ®Google Scholar
• Nah BS, Choi IB, Oh WY, Osborn JL, Song CW. Vascular thermal adaptation in tumors and normal tissue in rats. Int J Radiat Oncol Biol Phys 1996; 35: 95–101
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Dings RP, Jamshidi-Parsian A, Song CW. Mild temperature hyperthermia and radiation therapy: Role of tumour vascular thermotolerance and relevant physiological factors. Int J Hyperthermia 2010; 26: 256–263
   PubMed Web of Science ®Google Scholar
• Dewhirst M, Gross JF, Sim D, Arnold P, Boyer D. The effect of rate of heating or cooling prior to heating on tumor and normal tissue microcirculatory blood flow. Biorheology 1984; 21: 539–558
   PubMed Web of Science ®Google Scholar
• Jain RK. Determinants of tumor blood flow: A review. Cancer Res 1988; 48: 2641–2658
   PubMed Web of Science ®Google Scholar
• Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009; 136: 839–851
   PubMed Web of Science ®Google Scholar
• Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. Nat Med 2001; 7: 987–989
   PubMed Web of Science ®Google Scholar
• Ansiaux R, Baudelet C, Jordan BF, Beghein N, Sonveaux P, De Wever J, Martinive P, Gregoire V, Feron O, Gallez B. Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res 2005; 11: 743–750
   PubMed Web of Science ®Google Scholar
• Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ. Scheduling of radiation with angiogenesis inhibitors Anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res 2007; 13: 3395–3402
   PubMed Web of Science ®Google Scholar
• Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125: 1591–1598
   PubMed Web of Science ®Google Scholar
• Dings RP, Williams BW, Song CW, Griffioen AW, Mayo KH, Griffin RJ. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells. Int J Cancer 2005; 115: 312–319
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Ogawa A, Williams BW, Song CW. Hyperthermic enhancement of tumor radiosensitization strategies. Immunol Invest 2005; 34: 343–359
   PubMed Web of Science ®Google Scholar
• Vaupel P, Schlenger K, Knoop C, Hockel M. Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 1991; 51: 3316–3322
   PubMed Web of Science ®Google Scholar
• Dings RP, Chen X, Hellebrekers DM, van Eijk LI, Zhang Y, Hoye TR, Griffioen AW, Mayo KH. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities. J Natl Cancer Inst 2006; 98: 932–936
   PubMedGoogle Scholar
• Dings RP, van der Schaft DW, Hargittai B, Haseman J, Griffioen AW, Mayo KH. Anti-tumor activity of the novel angiogenesis inhibitor anginex. Cancer Lett 2003; 194: 55–66
   PubMed Web of Science ®Google Scholar
• Dings RP, Yokoyama Y, Ramakrishnan S, Griffioen AW, Mayo KH. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin. Cancer Res 2003; 63: 382–385
   PubMed Web of Science ®Google Scholar
• Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, Fan F, Bucana CD, McMahon G, Gallick GE, Ellis LM. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. Faseb J 2001; 15: 1239–1241
   PubMed Web of Science ®Google Scholar
• Dings RP, Van Laar ES, Webber J, Zhang Y, Griffin RJ, Waters SJ, MacDonald JR, Mayo KH. Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven. Cancer Lett 2008; 265: 270–280
   PubMed Web of Science ®Google Scholar
• Dings RP, Van Laar ES, Loren M, Webber J, Zhang Y, Waters SJ, Macdonald JR, Mayo KH. Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene. Bioconjug Chem 2010; 21: 20–27
   PubMed Web of Science ®Google Scholar
• Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004; 6: 553–563
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 2008; 8: 425–437
   PubMed Web of Science ®Google Scholar
• Horsman MR, Siemann DW. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies. Cancer Res 2006; 66: 11520–11539
   PubMed Web of Science ®Google Scholar
• Olch AJ, Kaiser LR, Silberman AW, Storm FK, Graham LS, Morton DL. Blood flow in human tumors during hyperthermia therapy: Demonstration of vasoregulation and an applicable physiological model. J Surg Oncol 1983; 23: 125–132
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Lee SH, Rood KL, Stewart MJ, Lyons JC, Lew YS, Park H, Song CW. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia 2000; 2: 555–560
   PubMed Web of Science ®Google Scholar
• Okajima K, Griffin RJ, Iwata K, Shakil A, Song CW. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: Dependence on heat dose and tumor type. Radiat Res 1998; 149: 294–299
   PubMed Web of Science ®Google Scholar
• Bicher HI, Hetzel FW, Sandhu TS, Frinak S, Vaupel P, O'Hara MD, O'Brien T. Effects of hyperthermia on normal and tumor microenvironment. Radiology 1980; 137: 523–530
   PubMed Web of Science ®Google Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 1984; 44: 4721s–4730s
   PubMed Web of Science ®Google Scholar
• Vaupel PW, Otte J, Manz R. Oxygenation of malignant tumors after localized microwave hyperthermia. Radiat Environ Biophys 1982; 20: 289–300
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Okajima K, Ogawa A, Song CW. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing. Int J Radiat Biol 1999; 75: 1299–1306
   PubMed Web of Science ®Google Scholar
• Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001; 155: 515–528
   PubMed Web of Science ®Google Scholar
• Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979; 52: 650–656
   PubMed Web of Science ®Google Scholar
• Masunaga S, Nagasawa H, Uto Y, Hori H, Suzuki M, Nagata K, Kinashi Y, Ono K. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations. Int J Hyperthermia 2005; 21: 305–318
   PubMed Web of Science ®Google Scholar
• Kirkpatrick JP, Brizel DM, Dewhirst MW. A mathematical model of tumor oxygen and glucose mass transport and metabolism with complex reaction kinetics. Radiat Res 2003; 159: 336–344
   PubMed Web of Science ®Google Scholar
• Thews O, Li Y, Kelleher DK, Chance B, Vaupel P. Microcirculatory function, tissue oxygenation, microregional redox status and ATP distribution in tumors upon localized infrared-A-hyperthermia at 42°C. Adv Exp Med Biol 2003; 530: 237–247
   PubMed Web of Science ®Google Scholar
• Vaupel P, Ostheimer K, Muller-Klieser W. Circulatory and metabolic responses of malignant tumors during localized hyperthermia. J Cancer Res Clin Oncol 1980; 98: 15–29
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Nielsen OS. Thermotolerance in the mouse foot estimated at various levels of normal tissue damage. Int J Radiat Oncol Biol Phys 1989; 16: 1543–1549
   PubMed Web of Science ®Google Scholar
• Saleem A, Price PM. Early tumor drug pharmacokinetics is influenced by tumor perfusion but not plasma drug exposure. Clin Cancer Res 2008; 14: 8184–8190
   PubMedGoogle Scholar